Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dr. Voodoo who wrote (1750)	1/15/1998 8:43:00 PM
From: Bill Wexler	Read Replies (1) \| Respond to of 7041

<<What in your mind figures as reasonable odds that SGP will dump Zona anytime in the near future>> SGP will not "dump" ZONA publicly. However, I am extremely confident that they are quietly backing away. <<A point that I want to make. Patent litigation, press releases, scams and scandals have NOTHING to do with FDA approval>> Good point and quite accurate. However, Zonagen made a terrible mistake. The whole impetus behind the Vasomax scam was to ride the ED wave. From what I've been able to glean, targeting Vasomax for the MED market was a very haphazard decision and was motivated solely to pump the stock price. Vasomax will not be approved for ED for two very simple reasons: 1) There is zero evidence that Phentolamine is effective in treating MED. 2) The Vasomax 40mg dose is too close to the toxic dose.